Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax

Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax

US Patent 8926986 · Granted Jan 6, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified anthrax toxin protective antigen2020
Clostridium difficile lipoteichoic acid and uses thereof2019
Antibodies to tumor endothelial marker 82019
Protease-deficient bacillus anthracis2019
Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin2019
Monoclonal antibodies that neutralize anthrax toxins2018
Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis 2018
Monoclonal antibodies that react with the capsule of bacillus anthracis2017
Monoclonal antibodies that react with the capsule of bacillus anthracis2017
Saccharides and uses thereof2017
Engineered anthrax lethal toxin for targeted delivery2017
Monoclonal antibodies that neutralize anthrax toxins2017